Healthcare entity

Citigroup

Company C

Every one of those 2 sits in a single category, medical-devices. Of the tracked stories, 2 of 2 also mention Wells Fargo & Company, the most common co-covered peer. The 140-day window averages about 0.1 stories each week. At 5, the average consequence score sits below the same-window beat average of 6.

Last mentioned: 1h ago

Entity pulse

Recent coverage · Citigroup

2 stories
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Citigroup

Every one of those 2 sits in a single category, medical-devices. Of the tracked stories, 2 of 2 also mention Wells Fargo & Company, the most common co-covered peer. The 140-day window averages about 0.1 stories each week. At 5, the average consequence score sits below the same-window beat average of 6. They are less corroborated than the beat average, carrying 2 original sources each against 3.6 for the same window. Citigroup appears in 2 tracked Healthcare stories published from February 21, 2026 through July 10, 2026.

Stories tracked
2
Per week
0.1
Sources per story
2

Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 779 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Citigroup. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Citigroup 2

Medical Devices Neutral

Wells Fargo Upgrades AxoGen to Strong-Buy as Nerve Repair Market Gains Momentum

AxoGen (NASDAQ: AXGN) has received a significant rating upgrade to "Strong-Buy" from Wells Fargo, signaling robust institutional confidence in the peripheral nerve repair specialist. This move, coupled with price target hikes from Jefferies and positive outlooks from Citigroup, underscores a bullish sentiment for the company's clinical and commercial trajectory.

2 sources

Source: Ticker Report · Watch List News

Citigroup is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.